Premium
Determinants of gingival overgrowth severity in organ transplant patients
Author(s) -
Thomason J. Mark,
Seymour Robin A.,
Ellis Janice S.,
Kelly Peter J.,
Parry Gareth,
Dark John,
Wilkinson Robert,
Ilde Jeffrey R.
Publication year - 1996
Publication title -
journal of clinical periodontology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.456
H-Index - 151
eISSN - 1600-051X
pISSN - 0303-6979
DOI - 10.1111/j.1600-051x.1996.tb00586.x
Subject(s) - medicine , organ transplantation , dentistry , dermatology , transplantation
The role of HLA phenotype as a risk factor for drug‐induced gingival overgrowth was investigated in a cohort of 172 transplant recipients. Clinically significant overgrowth warranting surgical correction was observed in 72 patients (42%). Using stepwise regression modelling. 6 clinical parameters were identified as significant risk factors for the severity of gingival overgrowth. These were; age. sex. creatinine plasma level, duration of therapy, papilla bleeding index and concomitant medication with a calcium channel blocking drug. 3 HLA alleles were also identified as risk factors when adjusted for other clinically significant risk factors (HLA ‐DR2, A24, B37). However, when the p‐values for the HLA variables were corrected to compensate for the use of multiple significance testing, only HLA‐B37 remained statistically significant at the 5% level. Organ transplant patients are at risk of developing gingival overgrowth, with approximately 25% medicated with cyclosporin alone requiring corrective gingival surgery. This figure more than doubles in patients concomitantly medicated with a calcium blocking drug. The data at present available would suggest that the severity of gingival overgrowth is also significantly associated with the HLA‐B37 phenotype.